These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 27144293

  • 1. Novel trans-Stilbene-based Fluorophores as Probes for Spectral Discrimination of Native and Protofibrillar Transthyretin.
    Campos RI, Wu X, Elgland M, Konradsson P, Hammarström P.
    ACS Chem Neurosci; 2016 Jul 20; 7(7):924-40. PubMed ID: 27144293
    [Abstract] [Full Text] [Related]

  • 2. trans-Stilbenoids with Extended Fluorescence Lifetimes for the Characterization of Amyloid Fibrils.
    Zhang J, Sandberg A, Wu X, Nyström S, Lindgren M, Konradsson P, Hammarström P.
    ACS Omega; 2017 Aug 31; 2(8):4693-4704. PubMed ID: 31457755
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transthyretin Binding Mode Dichotomy of Fluorescent trans-Stilbene Ligands.
    Begum A, Zhang J, Derbyshire D, Wu X, Konradsson P, Hammarström P, von Castelmur E.
    ACS Chem Neurosci; 2023 Mar 01; 14(5):820-828. PubMed ID: 36780206
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
    Sörgjerd K, Ghafouri B, Jonsson BH, Kelly JW, Blond SY, Hammarström P.
    J Mol Biol; 2006 Feb 17; 356(2):469-82. PubMed ID: 16376939
    [Abstract] [Full Text] [Related]

  • 8. A competition assay to identify amyloidogenesis inhibitors by monitoring the fluorescence emitted by the covalent attachment of a stilbene derivative to transthyretin.
    Choi S, Kelly JW.
    Bioorg Med Chem; 2011 Feb 15; 19(4):1505-14. PubMed ID: 21273081
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y, Ore MO, Morin S, Wilson DJ.
    Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW.
    Amyloid; 2006 Jun 24; 13(2):57-66. PubMed ID: 16911959
    [Abstract] [Full Text] [Related]

  • 16. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z, Colón W, Kelly JW.
    Biochemistry; 1996 May 21; 35(20):6470-82. PubMed ID: 8639594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
    Julius RL, Hawthorne MF.
    Drug News Perspect; 2008 Jun 21; 21(5):258-66. PubMed ID: 18596990
    [Abstract] [Full Text] [Related]

  • 19. Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.
    Schonhoft JD, Monteiro C, Plate L, Eisele YS, Kelly JM, Boland D, Parker CG, Cravatt BF, Teruya S, Helmke S, Maurer M, Berk J, Sekijima Y, Novais M, Coelho T, Powers ET, Kelly JW.
    Sci Transl Med; 2017 Sep 13; 9(407):. PubMed ID: 28904227
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.